Latest period
−$1.07B
YoY change
+60.9%
5Y CAGR
—
Peak year (2018)
−$286.00K
Latest annual
−$913.73M
Free Cash Flow history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: −$913.73M
Free Cash Flow growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +60.9%
Free Cash Flow history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | −$913.73M | +60.9% | −$345.99M | ||
| 2024 | −$567.74M | +58.5% | −$209.44M | ||
| 2023 | −$358.30M | +52.3% | −$123.08M | ||
| 2022 | −$235.22M | +53.0% | −$81.51M | ||
| 2021 | −$153.71M | +49.2% | −$50.71M | ||
| 2020 | −$103.00M | +97.3% | −$50.79M | ||
| 2019 | −$52.20M | +18153.5% | −$51.92M | ||
| 2018 | −$286.00K | -98.9% | +$26.44M | ||
| 2017 | −$26.72M | — | — |
- 2025−$913.73M+60.9%
- 2024−$567.74M+58.5%
- 2023−$358.30M+52.3%
- 2022−$235.22M+53.0%
- 2021−$153.71M+49.2%
- 2020−$103.00M+97.3%
- 2019−$52.20M+18153.5%
- 2018−$286.00K-98.9%
- 2017−$26.72M—
Free Cash Flow values are taken from Revolution Medicines's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Revolution Medicines (RVMD)
Free Cash Flow for Revolution Medicines (RVMD): headline value −$1.07B · YoY +60.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Revolution Medicines (RVMD) reported free cash flow of −$913.73M – surged 60.9% year-over-year.
The record annual free cash flow stands at −$286.00K, reached in 2018; the historical low of −$913.73M was recorded in 2025.
Revolution Medicines Free Cash Flow by Year
Revolution Medicines Free Cash Flow 2025: −$913.73M
Revolution Medicines posted free cash flow of −$913.73M in 2025, surged 60.9% from 2024. This figure represents the lowest annual value in the available history.
Revolution Medicines Free Cash Flow 2024: −$567.74M
In 2024, Revolution Medicines reported free cash flow of −$567.74M, surged 58.5% from 2023.
Revolution Medicines Free Cash Flow 2023: −$358.30M
Revolution Medicines free cash flow in 2023 was −$358.30M, surged 52.3% from 2022.
Revolution Medicines Free Cash Flow 2022: −$235.22M
2022's free cash flow for Revolution Medicines came in at −$235.22M, surged 53.0% from 2021.
Revolution Medicines Free Cash Flow 2021: −$153.71M
Revolution Medicines free cash flow in 2021 was −$153.71M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Free Cash Flow
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation